WHO confirms three new drugs for COVID-19 clinical trials

August 11, 2021
Tedros Adhanom Ghebreyesus

The World Health Organisation (WHO) confirmed on Wednesday that three new drugs are undergoing clinical trials in a bid to find effective treatments for COVID-19.

The WHO Director-General, Dr. Tedros Ghebreyesus, who disclosed this at a press conference in Geneva, Switzerland, listed the drugs as Artesunate, Imatinib and Infliximab.

The drugs, according to him, will be tested on COVID-19 patients in 52 countries across the world under the Solidarity PLUS programme.

The WHO chief revealed that there are 203 million confirmed COVID-19 cases across the world.

Leave a Reply

Your email address will not be published. Required fields are marked *

WP2Social Auto Publish Powered By : XYZScripts.com